HomeNewslettersMammary Cell NewsMolecular Classification of Hormone Receptor-Positive /HER2-Positive Breast Cancer Reveals Potential Neoadjuvant Therapeutic...
Investigators conducted molecular typing on a cohort of 211 patients with HR+/HER2+ breast cancer and performed a comprehensive analysis of the efficacy of various neoadjuvant treatment regimens.